Skip to content
2000
Volume 18, Issue 2
  • ISSN: 1874-4710
  • E-ISSN: 1874-4729

Abstract

Background

Gated SPECT is an established technique for assessment of left ventricular function in cardiovascular disease patients. However, there is little information about the influence of diabetes mellitus on gated SPECT parameters. This study was established to assess gated SPECT parameters in Diabetes Mellitus (DM) and non-diabetes mellitus (non-DM) patients with normal Myocardial Perfusion Imaging (MPI).

Methods

In this analytical cross-sectional study, 314 patients (157 DM, 157 non-DM) with normal MPI were enrolled. Prevalence of risk factors for CAD like hypertension (HTN), and dyslipidemia were found to be significantly higher () in DM patients compared to non-DM.

Results

No statistically significant difference was observed among the TID, ESV, EDV, PFR, TTPF, and Wall Thickness (WT) parameters between DM and non-DM patients. Wall motion (Wm) in DM patients was significantly higher compared to non-DM patients. (3.9 ± 0.51 . 2.69 ± 0.48 for DM and non-DM patients, respectively, ). Also, there was no significant difference in Wm in the two groups with and without HTN. This shows the independent effect of DM on the Wm.

Conclusion

This study believes that the Wm parameter should be noted for the early diagnosis or prevention of heart disease in DM patients. These findings can indicate the gradual changes in the movements of the left ventricle and the beginning of the progression of diabetic cardiomyopathy.

Loading

Article metrics loading...

/content/journals/crp/10.2174/0118744710312688240814100448
2024-08-27
2025-06-23
Loading full text...

Full text loading...

References

  1. ZhengY. LeyS.H. HuF.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.Nat. Rev. Endocrinol.2018142889810.1038/nrendo.2017.15129219149
    [Google Scholar]
  2. KatsikiN. FerranniniE. MantzorosC. New American diabetes association (ada)/european association for the study of diabetes (easd) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician’s perspective.Metabolism202010715421810.1016/j.metabol.2020.15421832222374
    [Google Scholar]
  3. ValensiP. HenryP. BoccaraF. CossonE. PrevostG. EmmerichJ. ErnandeL. MarcadetD. MousseauxE. RouzetF. SultanA. FerrièresJ. VergèsB. Van BelleE. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology.Arch. Cardiovasc. Dis.2021114215017210.1016/j.acvd.2020.07.00333309203
    [Google Scholar]
  4. ShaghaghiZ. FarzipourS. JalaliF. AlvandiM. Ferroptosis inhibitors as new therapeutic insights into radiation-induced heart disease.Cardiovasc. Hematol. Agents Med. Chem.20232112910.2174/187152572066622071310173635838214
    [Google Scholar]
  5. HeneinM.Y. VancheriS. VancheriF. 8 - Diabetes and coronary circulation: From pathology to imaging.Diabetes and Cardiovascular Disease. El-BazA.S. SuriJ.S. Elsevier202122726710.1016/B978‑0‑12‑817428‑9.00008‑5
    [Google Scholar]
  6. HenningR.J. Type-2 diabetes mellitus and cardiovascular disease.Future Cardiol.201814649150910.2217/fca‑2018‑004530409037
    [Google Scholar]
  7. TheofilisP. SagrisM. AntonopoulosA.S. OikonomouE. TsioufisK. TousoulisD. Non-invasive modalities in the assessment of vulnerable coronary atherosclerotic plaques.Tomography2022841742175810.3390/tomography804014735894012
    [Google Scholar]
  8. BellerG.A. HeedeR.C. SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability.J. Cardiovasc. Transl. Res.20114441642410.1007/s12265‑011‑9290‑221732226
    [Google Scholar]
  9. VillemainO. BarangerJ. JalalZ. LamC. CalaisJ. PernotM. CifraB. FriedbergM.K. MertensL. Non-invasive imaging techniques to assess myocardial perfusion.Expert Rev. Med. Devices202017111133114410.1080/17434440.2020.183484433044100
    [Google Scholar]
  10. CzajaM.Z. WygodaZ. DuszańskaA. SzczerbaD. GłowackiJ. GąsiorM. WasilewskiJ.P. Myocardial perfusion scintigraphy – interpretation of gated imaging. Part 2.Kardiochir. Torakochirurgia Pol.2018151495610.5114/kitp.2018.7467629681962
    [Google Scholar]
  11. WalkerA.M.N. PatelP.A. RajwaniA. GrovesD. DenbyC. KearneyL. SapsfordR.J. WitteK.K. KearneyM.T. CubbonR.M. Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction.Diab. Vasc. Dis. Res.201613533134010.1177/147916411665334227334485
    [Google Scholar]
  12. HämäläinenH. HedmanM. LaitinenT. HedmanA. KiveläA. LaitinenT. Reference values for left ventricular systolic synchrony according to phase analysis of ECG ‐gated myocardial perfusion SPECT.Clin. Physiol. Funct. Imaging2018381384510.1111/cpf.1237927453042
    [Google Scholar]
  13. PaulA.K. NabiH.A. Gated myocardial perfusion SPECT: Basic principles, technical aspects, and clinical applications.J. Nucl. Med. Technol.200432417918715576339
    [Google Scholar]
  14. KapitanM. BeltranA. BerettaM. MutF. Left ventricular functional parameters by gated SPECT myocardial perfusion imaging in a Latin American country.J. Nucl. Cardiol.201825265266010.1007/s12350‑017‑0788‑028155191
    [Google Scholar]
  15. ChantadisaiM. SirisalipochS. VachatimanontS. Utility of gated SPECT parameters in detection of coronary artery disease in patients with normal perfusion images.Egypt. J. Radiol. Nucl. Med.202253125710.1186/s43055‑022‑00944‑4
    [Google Scholar]
  16. HosseinzadehE. GhodsiradM.A. AlirezaeiT. ArfeniaM. Pirayesh AmoieeM. NorouziG.H. Comparing left ventricular mechanical dyssynchrony between diabetic and non-diabetic patients with normal gated SPECT MPI.Int. J. Cardiovasc. Imaging202238124925610.1007/s10554‑021‑02358‑134313890
    [Google Scholar]
  17. KorkmazA. CaliskanB. ErdemF. Evaluation of diastolic function in patients with normal perfusion and type 2 diabetes mellitus with gated single-photon emission computed tomography.World J. Nucl. Med.201716320621110.4103/1450‑1147.20727828670179
    [Google Scholar]
  18. AbidovA. GermanoG. HachamovitchR. SlomkaP. BermanD.S. Gated SPECT in assessment of regional and global left ventricular function: An update.J. Nucl. Cardiol.20132061118114310.1007/s12350‑013‑9792‑124234974
    [Google Scholar]
  19. DjaberiR. BeishuizenE.D. PereiraA.M. RabelinkT.J. SmitJ.W. TamsmaJ.T. HuismanM.V. JukemaJ.W. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus.Diabetologia20085191581159310.1007/s00125‑008‑1062‑418607561
    [Google Scholar]
  20. GilcaG.E. StefanescuG. BadulescuO. TanaseD.M. BararuI. CiocoiuM. Diabetic cardiomyopathy: Current approach and potential diagnostic and therapeutic targets.J. Diabetes Res.201720171710.1155/2017/131026528421204
    [Google Scholar]
  21. SalonenJ.T. LakkaT.A. LakkaH.-M. ValkonenV.-P. EversonS.A. KaplanG.A. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men.Diabetes202447227027510.2337/diab.47.2.270
    [Google Scholar]
  22. RatkiS.K.R. NamiranianN. AlvandiM. Impact of Phase Analysis of Gated SPECT to Assessment of Left Ventricular Mechanical Dyssynchrony in Diabetic Patients with Normal MPI.Iranian J. Diabet. Obes.201793
    [Google Scholar]
  23. NasrH. AlsomaliH. SaadI. AbdElaalA. MohamadienN. Association between glycated hemoglobin (HbA1c) level and cardiac perfusion and function on gated myocardial perfusion SPECT.Egypt. J. Radiol. Nucl. Med.20235418510.1186/s43055‑023‑01036‑7
    [Google Scholar]
/content/journals/crp/10.2174/0118744710312688240814100448
Loading
/content/journals/crp/10.2174/0118744710312688240814100448
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test